Trospium Chloride Capsule, Extended Release
Product Images NDC 63629-8458

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 63629-8458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
This is a table displaying the plasma concentration (in ng/mL) of Trospium Chloride Extended-Release Capsules, with readings taken at 0, 2, 16, 22 hours post-dose.*
FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure 3 (Image 04)

FDA Label Image

Figure 4 (Image 05)

Figure 4 (Image 05)
This text appears to be a table or graph showing the average change and standard error in a study involving a placebo group (n=276) and a group taking trospium chloride extended-release capsules (n=267). However, without additional context or information, it is difficult to provide a more detailed description of what the study is evaluating.*
FDA Label Image

Figure 5 (Image 06)

FDA Label Image

Label (Lbl636298458)

Label (Lbl636298458)
Trospium Chloride Extended-Release Capsules are a prescription medication that contains 60mg of Trospium Chloride in each capsule. It is important to keep the medicine out of the reach of children and store it at a temperature range of 20°C to 25°C. The medication should be dispensed in a tightly sealed container. The NILD VSN number for the capsule is #0516YO "ueaing".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.